Pediatric Doses vs Residipok

Pediatric Prescription Made Simple! Calculate drug doses, equipment sizes, and IV fluids with precision. Transform your practice with intuitive app. Make pediatric care easier with our Pediatric Doses app. Just enter a child's weight, and quickly get the right drug doses, equipment sizes, and IV fluid amounts. It's accurate and works for newborns to older kids. Create your own pediatric dose notebook — add custom drug categories and medications tailored to your practice, and let the app calculate doses automatically. Pediatric Doses is easy to use, making your work smoother and more efficient. It's designed for all healthcare professionals, fitting right into your daily routine. With regular updates, Pediatric Doses keeps you up-to-date, helping you provide the best care for kids. Get all the calculations you need fast, all in one place. Also, Pediatric Doses has a simple design that ensures accessibility for all healthcare professionals, fostering a seamless integration into your daily workflow. Stay updated with regular enhancements, and elevate the standards of pediatric care with precise calculations at your fingertips. Terms of Use: https://hvalabs.com/terms-and-conditions/

Residipok is a pocket reference for licensed healthcare professionals, trainees, and medical students of accredited health-professions programs. TWO MODULES (v0.4) • MIC Lookup Choose a bacterium and an antibiotic to see the EUCAST v16.0 (2026) Clinical Breakpoint thresholds — S, I, R bands by clinical context (systemic, meningitis, urinary, high-dose). Enter an MIC value to categorise it. Special states clearly labelled when no breakpoint is published or the organism is intrinsically resistant. Built especially for pan-resistance scenarios where every threshold matters. • ESC Guideline Reference Structured Class / Level of Evidence summaries of recent ESC cardiology guidelines, covering acute coronary syndromes, heart failure, atrial fibrillation, hypertension, endocarditis, cardiomyopathies, valvular disease, pulmonary hypertension and embolism, peripheral arterial disease, dyslipidaemia, prevention, pregnancy, syncope, supraventricular tachycardia, and more. Each recommendation card links back to the original guideline on escardio.org. IMPORTANT — REFERENCE ONLY • Residipok is NOT a medical device. • It does NOT diagnose, treat, cure, or prevent disease. • It is NOT a substitute for clinical judgement or for the original published guideline / breakpoint table. • Always verify against the current EUCAST table and the latest ESC document before clinical reporting. Requires confirmation of HCP / trainee status on first launch. Sign-in by email, Apple, or Google. Sources: EUCAST Clinical Breakpoint Tables v16.0 (2026); European Society of Cardiology Clinical Practice Guidelines (2018–2024).